Theresa May failed to tackle “country’s biggest injustices”, says NHS
Back in 2018 she announced that the NHS was to receive an extra £20 billion a year by 2023.
28th May 2019
Latest news
Santhera submits MAA to EMA for Puldysa
The company is seeking conditional marketing authorisation (CMA) for patients with DMD who are not using glucocorticoids.
28th May 2019
New molecular diagnostics business launched in Manchester
The aim of APIS Assay Technologies is to help to realise the clinical and commercial potential of genomic medicine in diagnostic tests and personalisation of treatment.
28th May 2019
Zolgensma wins FDA green light in child SMA
The $2.1 milllion per treatment price tag has garnered substantial criticism.
28th May 2019
Final NICE guidance issued for Akcea’s Tegsedi
The drug should be available for routine use within 90 days for patients in England.
24th May 2019
GSK updates its sales rep incentives
The company implemented stricter rules in 2012 as part of a broad transparency initiative.
24th May 2019
NHS to undergo ‘ambitious’ tech overhaul
In the past three months alone, the NHS has prevented more than 21 million potential cyber attacks.
24th May 2019
AZ’ HER2 drug hits mid-stage trial endpoints
The drug has been granted US FDA Breakthrough Therapy Designation and Fast Track Designation.
24th May 2019
LifeArc receives $1.2b in Keytruda royalties
In 2016, LifeArc sold a small proportion of its Keytruda royalty interest for $150 million to a private equity fund.
24th May 2019
CMA accuses four pharmas of anticompetitive behaviour
Four pharma companies stand accused in the UK of colluding to artificially inflate the price of prescription-only, anti-nausea and dizziness drug prochlorperazine, costing the NHS millions of pounds and breaking competition law.
23rd May 2019
Scancell, CR UK publish joint vaccine update
SCIB2 is to be administered using a new nanoparticle formulation in a planned Phase I/II clinical trial.
23rd May 2019
Vulnerable children stuck in mental health hospitals for too long
Too many children are being admitted to secure hospitals unnecessarily, and in some cases are spending months and years of their childhood in institutions.
23rd May 2019
New data highlights value of Janssen’s Spravato
The approval of the drug is a new way of treating adults with TRD that is unlike other treatment options in psychiatry.
23rd May 2019
Insilico, ARK initiate health-span and longevity partnership
The newly developed ‘ARK’ will develop a programme of events to facilitate networking in AI research across King’s.
23rd May 2019
KCL findings could improve STI vaccines
Researchers have shown how skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues.
22nd May 2019
